nad has been researched along with Cranial Nerve II Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pietris, J | 1 |
| Fujino, H; Hayashi, Y; Kitaoka, Y; Kumai, T; Lam, TT; Munemasa, Y; Sadun, AA; Takeda, H; Ueno, S | 1 |
1 review(s) available for nad and Cranial Nerve II Diseases
| Article | Year |
|---|---|
The Role of NAD
Topics: Animals; Female; Glaucoma; Humans; Mice; NAD; Niacinamide; Optic Nerve Diseases; Retinal Ganglion Cells | 2022 |
1 other study(ies) available for nad and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy.
Topics: Animals; Axons; Chromatography, High Pressure Liquid; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Male; Microscopy, Electron, Transmission; NAD; Nerve Tissue Proteins; Nicotinamide-Nucleotide Adenylyltransferase; Optic Nerve Diseases; Rats; Rats, Wistar; Retinal Ganglion Cells; RNA, Messenger; Statistics, Nonparametric; Stilbamidines; Time Factors; Tumor Necrosis Factor-alpha | 2009 |